CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up

benzinga.com/25/05/45418724/new-cms-guidance-raises-concerns-over-subcutaneous-drug-inclusion-goldman-sachs-sees-as-another-aspect-of-policy-

The U.S. Centers for Medicare & Medicaid Services (CMS) on Monday issued a draft guidance for public comment on the third cycle of negotiations under the Medicare Drug Price Negotiation Program (Negotiation Program) to lower prescription drug prices.
The draft guidance introduces new…

This story appeared on benzinga.com, 2025-05-14 19:26:48.
The Entire Business World on a Single Page. Free to Use →